Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Beta Bionics Inc. CFO Stephen Feider conducted concurrent stock option exercises and share sales in late June, moving 10,000 shares under a Rule 10b5-1 plan. The transactions occurred as the biotech firm reported first-quarter revenue that exceeded Wall Street estimates and updated its financial guidance. Analysts adjusted price targets following t…
Neurogene Inc. (NASDAQ:NGNE) President and Chief Financial Officer Christine Mikail Cvijic sold a total of 4,800 shares of the company's common stock between July 1 and July 2, 2026. The transactions, valued at approximately $166,586, were conducted under a Rule 10b5-1 trading plan established in August 2025. The sale occurred as Neurogene's stock …
Ormat Technologies Inc. (NASDAQ: ORA) Executive Vice President Aron John Willis executed a transaction involving the sale of 451 shares on July 1, 2026. The divestiture, totaling $48,094, was structured to satisfy tax withholding obligations associated with the vesting of restricted stock units. This event occurs against a backdrop of operational e…
Margaret Knight, a director at Exodus Movement, Inc. (EXOD), executed a sale of 135 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at $710 based on a per-share price of $5.26, reduces Knight's direct holdings to 12,698 shares. This portfolio adjustment follows the company's release of first-quarter 2026 financ…
Stacey G. Rock, President of the KTT Division at Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), executed a sale of 4,675 shares of the company's common stock on June 30, 2026. The transaction, valued at $233,750, was conducted at a price of $50.00 per share. The sale was part of a 10b5-1 trading plan adopted by Ms. Rock on June 16, 2025. …
Roku, Inc. (NASDAQ: ROKU) director Neil Hunt executed a series of sales totaling approximately $281,306 in Class A Common Stock on July 1, 2026. The transactions were conducted under a pre-arranged 10b5-1 trading plan. At the time of the report, Roku shares were trading near their 52-week high, with recent analyst downgrades reflecting concerns ove…
Christine Ring, Chief Legal Officer at Nurix Therapeutics, Inc. (NASDAQ:NRIX), executed a sale of company equity totaling $259,366 on July 2, 2026. The transaction was conducted under a Rule 10b5-1 trading plan. The sale occurs as the stock trades near a 52-week high of $24.88, following a 93% gain over the past year. According to InvestingPro anal…
Richard Todd Schwartz, Chief Executive Officer and a director of Rush Street Interactive, Inc. (NASDAQ:RSI), executed a series of transactions on July 1, 2026, selling 158,334 shares of Class A Common Stock. The sales, conducted under a pre-arranged 10b5-1 trading plan, generated approximately $4,942,364 at a weighted average price of $31.2148 per …
Hartree Partners, LP, a significant 10% shareholder in Hudson Technologies Inc. (NASDAQ:HDSN), has executed a substantial purchase of the company's common stock. This acquisition brings the fund's total direct holdings to 4,971,302 shares. The buying activity occurs against a backdrop of mixed corporate developments, including a recent earnings mis…
Jolanda Howe, Senior Vice President and Global Controller at Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), executed a sale of 2,721 common shares on July 1, 2026, valued at $326,520 at a price of $120.0 per share. This transaction, conducted under a Rule 10b5-1 plan established on March 18, 2026, leaves Howe with a direct holding of 3,114 shares. The …
Kevin Bryan Williams, a director at Voip-Pal.com Inc. (OTCQB: VPLM), executed a sale of 250,000 shares of the company's common stock on June 29, 2026. The transaction, valued at $2,500, occurred at a price of $0.01 per share. Following this divestment, Williams retains a direct holding of 4,421,885 shares. The company currently reports a market cap…
Jennifer Catherine Hartnett, Chief Commercial Officer at e.l.f. Beauty, Inc., executed a significant divestment of company shares on July 1, 2026, selling 25,357 shares at $80.00 per share. The transaction, totaling approximately $2,028,560, was conducted under a 10b5-1 trading plan adopted in June 2025. Following this sale, Hartnett retains direct…
Shannon O'Donnell, serving as Senior Vice President at Auburn National Bancorporation, Inc. (NASDAQ:AUBN), has expanded her direct ownership in the firm's common stock. The recent transactions involve the acquisition of 27 shares across two separate purchases on July 2, 2026. This activity occurs as the stock trades at $27.63, reflecting a 16% gain…
e.l.f. Beauty, Inc. (NYSE:ELF) Chief Executive Officer Tarang Amin executed a transaction involving the sale of 7,000 shares of the company's common stock on June 9, 2026. The transaction, valued at $360,710, was processed at a per-share price of $51.53. This filing, which serves as an amendment to a previous Form 4, corrects a scrivener’s error re…
Chief Executive Officer Tarang Amin of e.l.f. Beauty, Inc. (NASDAQ:ELF) executed a sale of approximately $3.9 million in company shares on July 1, 2026. The transaction involved the divestment of 50,164 shares at weighted average prices between $73.59 and $79.74. This sale was part of a broader activity where Mr. Amin simultaneously acquired an equ…
Mattias Stetz, Chief Operating Officer at Rush Street Interactive, Inc. (NASDAQ: RSI), sold 20,000 shares of Class A Common Stock on July 1, 2026, generating proceeds of $624,374. The transaction was executed under a pre-arranged 10b5-1 trading plan, with shares sold at prices between $30.42 and $31.67, averaging $31.2187. Following the sale, Stetz…
Daniel S. Lorrain, Chief Scientific Officer at Contineum Therapeutics, Inc. (NASDAQ: CTNM), completed a series of stock transactions totaling approximately $594,578 on June 30 and July 1, 2026. The sales were conducted under a pre-arranged 10b5-1 trading plan established on September 23, 2025. The transactions took place as Contineum's shares trade…
Tarang Amin, Chief Executive Officer of e.l.f. Beauty, Inc. (NASDAQ:ELF), recently executed a transaction involving the sale of 15,829 shares of the company's common stock on June 4, 2026. According to an amended Form 4 filing submitted to the Securities and Exchange Commission, the sale was conducted to satisfy tax withholding obligations associat…
David E. Housel, a director at Auburn National Bancorporation, Inc. (NASDAQ:AUBN), completed the purchase of 53 shares of the company's common stock on July 2, 2026. The acquisitions, totaling $1,411, were executed through a Dividend Reinvestment Plan or Optional Cash Purchase. Following the transaction, Housel holds a direct stake of 9,317 shares.…
William F. Ham Jr., a director at Auburn National Bancorporation, Inc. (NASDAQ:AUBN), purchased 57 shares of company common stock on July 2, 2026, through a Dividend Reinvestment Plan (DRIP) or Officer Compensation Plan (OCP). The transactions occurred at prices between $26.01 and $26.90 per share. Following this acquisition, Ham directly holds 5,0…
Jennifer H. Taylor, a director at Freshworks Inc. (NASDAQ: FRSH), sold 6,618 shares of the company’s Class A Common Stock on July 2, 2026, under a Rule 10b5-1 trading plan. The transaction, valued at $69,091, occurred at a weighted average price of $10.44 per share, with prices ranging from $10.33 to $10.53. This sale followed a significant equity …
Bernard Shek, Chief Legal Officer and Secretary at SanDisk Corp (NASDAQ:SNDK), executed a sale of 600 common stock shares totaling $1,252,800 on July 1, 2026, per an SEC Form 4 filing. The transaction followed a Rule 10b5-1 trading plan established on March 4, 2026. Post-sale, Shek retains a direct holding of 31,515 shares. The sale occurs against …
Kymera Therapeutics director Bruce Booth has executed a significant share disposal totaling $8.28 million, conducted through a pre-arranged trading plan linked to Atlas Venture funds. This transaction follows a period of accelerated clinical progress for the company's KT-621 program and subsequent analyst upgrades, highlighting the intersection of …
Todd Pollak, Chief Revenue Officer at Marqeta, Inc. (NASDAQ: MQ), executed a sale of 18,750 shares of the company's Class A Common Stock on July 1, 2026. The transaction, valued at $316,447, brings Pollak's direct holdings to 185,008 shares. This financial move coincides with significant corporate developments at Marqeta, including the announcement…
PEDEVCO CORP (NASDAQ: PED) Executive Vice President Clark Moore executed a sale of 18,797 shares on June 30, 2026, generating proceeds of approximately $275,789. The transaction takes place against a backdrop of recent financial reporting that highlights a massive revenue increase offset by substantial derivative-related losses. Analyst consensus r…
